Literature DB >> 15047557

Identification of the Haemophilus influenzae tolC gene by susceptibility profiles of insertionally inactivated efflux pump mutants.

Catherine M Trepod1, John E Mott.   

Abstract

Isogenic strains containing insertional disruptions of 10 Haemophilus influenzae Rd genes were investigated for their effects on the susceptibility of the organism to various classes of antimicrobial compounds. MIC results show that HI1462, which encodes an Escherichia coli TolC homolog, is the third component of the H. influenzae AcrAB pump.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047557      PMCID: PMC375248          DOI: 10.1128/AAC.48.4.1416-1418.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes.

Authors:  M C Sulavik; C Houseweart; C Cramer; N Jiwani; N Murgolo; J Greene; B DiDomenico; K J Shaw; G H Miller; R Hare; G Shimer
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Microbial genome analyses: comparative transport capabilities in eighteen prokaryotes.

Authors:  I T Paulsen; L Nguyen; M K Sliwinski; R Rabus; M H Saier
Journal:  J Mol Biol       Date:  2000-08-04       Impact factor: 5.469

3.  Differential effects of mutations in tonB1 on intrinsic multidrug resistance and iron acquisition in Pseudomonas aeruginosa.

Authors:  Qixun Zhao; Keith Poole
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

Review 4.  The role of the TolC family in protein transport and multidrug efflux. From stereochemical certainty to mechanistic hypothesis.

Authors:  A Sharff; C Fanutti; J Shi; C Calladine; B Luisi
Journal:  Eur J Biochem       Date:  2001-10

5.  A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae.

Authors:  Brian J Akerley; Eric J Rubin; Veronica L Novick; Kensey Amaya; Nicholas Judson; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

6.  The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump.

Authors:  L Sánchez; W Pan; M Viñas; H Nikaido
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

7.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd.

Authors:  R D Fleischmann; M D Adams; O White; R A Clayton; E F Kirkness; A R Kerlavage; C J Bult; J F Tomb; B A Dougherty; J M Merrick
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

8.  The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals.

Authors:  D Ma; M Alberti; C Lynch; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1996-01       Impact factor: 3.501

9.  Emr, an Escherichia coli locus for multidrug resistance.

Authors:  O Lomovskaya; K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

View more
  17 in total

1.  Elucidation of essential and nonessential genes in the Haemophilus influenzae Rd cell wall biosynthetic pathway by targeted gene disruption.

Authors:  Catherine M Trepod; John E Mott
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Characterization of TolC efflux pump proteins from Pasteurella multocida.

Authors:  Tamas Hatfaludi; Keith Al-Hasani; Michelle Dunstone; John Boyce; Ben Adler
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

Review 3.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 4.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

5.  Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.

Authors:  Charles R Dean; Shubha Narayan; Denis M Daigle; JoAnn L Dzink-Fox; Xiaoling Puyang; Kathryn R Bracken; Karl E Dean; Beat Weidmann; Zhengyu Yuan; Rakesh Jain; Neil S Ryder
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  A Helicobacter pylori TolC efflux pump confers resistance to metronidazole.

Authors:  Karin van Amsterdam; Aldert Bart; Arie van der Ende
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

7.  Clarithromycin Resistance Mechanisms of Epidemic β-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan.

Authors:  Shoji Seyama; Takeaki Wajima; Hidemasa Nakaminami; Norihisa Noguchi
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.

Authors:  Ruth E Caughlan; Shubha Sriram; Denis M Daigle; Angela L Woods; Jennifer Buco; Ron L Peterson; Joann Dzink-Fox; Susan Walker; Charles R Dean
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

9.  Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.

Authors:  Tatiana Bogdanovich; Bülent Bozdogan; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

10.  A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.

Authors:  Gregory T Robertson; Timothy B Doyle; Qun Du; Leonard Duncan; Khisimuzi E Mdluli; A Simon Lynch
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.